An exploration of the potential of metabolomics for the detection of recombinant human erythropoietin (r-HuEPO) abuse in sport
Recombinant human erythropoietin (r-HuEPO) administration stimulates the increase in red blood cell (RBC) mass and ultimately the oxygen carrying capacity of the blood, which results in its ergogenic benefits. EPO and its related forms are banned by the World Anti-Doping Agency. The main aim of this...
| Main Author: | |
|---|---|
| Published: |
University of Strathclyde
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.665225 |